Q4 EPS Estimate for Huron Consulting Group Raised by Analyst

Huron Consulting Group Inc. (NASDAQ:HURN - Free Report) - Equities research analysts at Barrington Research upped their Q4 2024 earnings per share estimates for Huron Consulting Group in a research report issued to clients and investors on Monday, November 4th. Barrington Research analyst K. Steinke now expects that the business services provider will post earnings of $1.52 per share for the quarter, up from their prior estimate of $1.50. Barrington Research currently has a "Outperform" rating and a $142.00 price target on the stock. The consensus estimate for Huron Consulting Group's current full-year earnings is $6.11 per share.

Huron Consulting Group (NASDAQ:HURN - Get Free Report) last issued its earnings results on Tuesday, October 29th. The business services provider reported $1.68 earnings per share for the quarter, topping the consensus estimate of $1.57 by $0.11. Huron Consulting Group had a return on equity of 21.51% and a net margin of 5.80%. The business had revenue of $370.00 million during the quarter, compared to analysts' expectations of $377.63 million. During the same period in the prior year, the business earned $1.39 EPS. The business's revenue for the quarter was up 3.3% compared to the same quarter last year.

Several other brokerages have also recently weighed in on HURN. Benchmark reaffirmed a "buy" rating and issued a $140.00 price target on shares of Huron Consulting Group in a research report on Wednesday, October 30th. StockNews.com raised shares of Huron Consulting Group from a "hold" rating to a "buy" rating in a research note on Thursday, October 31st. Five equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the company currently has an average rating of "Buy" and an average price target of $133.00.

Huron Consulting Group Stock Down 0.4 %

NASDAQ:HURN traded down $0.47 during mid-day trading on Thursday, reaching $127.66. The company's stock had a trading volume of 121,785 shares, compared to its average volume of 125,125. The company has a quick ratio of 1.61, a current ratio of 1.61 and a debt-to-equity ratio of 0.82. Huron Consulting Group has a 1 year low of $84.26 and a 1 year high of $131.06. The stock has a fifty day moving average of $108.91 and a 200-day moving average of $101.74. The firm has a market capitalization of $2.26 billion, a PE ratio of 27.75 and a beta of 0.60.

Insider Buying and Selling at Huron Consulting Group

In related news, Director H Eugene Lockhart sold 1,042 shares of the business's stock in a transaction that occurred on Tuesday, September 3rd. The shares were sold at an average price of $109.48, for a total transaction of $114,078.16. Following the completion of the transaction, the director now owns 29,882 shares in the company, valued at $3,271,481.36. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. In other Huron Consulting Group news, CEO C. Mark Hussey sold 4,000 shares of the firm's stock in a transaction dated Monday, August 12th. The stock was sold at an average price of $103.13, for a total value of $412,520.00. Following the completion of the sale, the chief executive officer now owns 81,081 shares of the company's stock, valued at approximately $8,361,883.53. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director H Eugene Lockhart sold 1,042 shares of the company's stock in a transaction dated Tuesday, September 3rd. The shares were sold at an average price of $109.48, for a total transaction of $114,078.16. Following the transaction, the director now owns 29,882 shares in the company, valued at approximately $3,271,481.36. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 7,348 shares of company stock valued at $783,392. 2.20% of the stock is currently owned by insiders.

Institutional Trading of Huron Consulting Group

A number of institutional investors have recently bought and sold shares of HURN. Quest Partners LLC raised its holdings in shares of Huron Consulting Group by 131.9% in the third quarter. Quest Partners LLC now owns 13,814 shares of the business services provider's stock worth $1,502,000 after buying an additional 7,858 shares during the last quarter. Natixis Advisors LLC increased its position in shares of Huron Consulting Group by 32.7% in the 3rd quarter. Natixis Advisors LLC now owns 18,571 shares of the business services provider's stock valued at $2,019,000 after acquiring an additional 4,576 shares during the period. Chartwell Investment Partners LLC raised its stake in Huron Consulting Group by 43.3% in the 3rd quarter. Chartwell Investment Partners LLC now owns 8,196 shares of the business services provider's stock worth $891,000 after acquiring an additional 2,477 shares during the last quarter. Assetmark Inc. lifted its position in Huron Consulting Group by 7.0% during the 3rd quarter. Assetmark Inc. now owns 1,373 shares of the business services provider's stock worth $149,000 after acquiring an additional 90 shares during the period. Finally, Olympiad Research LP purchased a new stake in Huron Consulting Group during the 3rd quarter valued at about $299,000. 93.90% of the stock is currently owned by institutional investors and hedge funds.

About Huron Consulting Group

Huron Consulting Group Inc, a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides financial and operational performance improvement consulting services; digital offerings, spanning technology and analytic-related services; software products; organizational transformation services; revenue cycle managed and outsourcing services; financial and capital advisory consulting services; and strategy and innovation consulting services to national and regional health systems, academic and community health systems, federal health system, public, children's and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers.